drugset / Trial / NCT01613690
Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to see how the body processes and gets rid of NVA237 in people who have impaired kidney function compared to people whose kidney function is normal.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | 100 ug | — |